Qin et al. [22] also found that XRCC2-deficient cancer cells were more sensitive to irradiation in vitro and speculated that the inhibition of XRCC2 expression or activity represents a potential therapeutic strategy for improving preoperative radiotherapy responses in patients with locally advanced rectal cancer. Here, XRCC2 is linked to rectal cancer.